BWL
REGN icon

Bogart Wealth LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Bogart Wealth LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7K Buy
22
+2
+10% +$1.36K ﹤0.01% 916
2026
Q1 		$15.5K Buy
20
+4
+25% +$3.06K ﹤0.01% 787
2025
Q4 		$12.3K Buy
16
+1
+7% +$679 ﹤0.01% 816
2025
Q3 		$8.43K Buy
15
+3
+25% +$1.7K ﹤0.01% 864
2025
Q2 		$6.3K Sell
12
-17
-59% -$9.49K ﹤0.01% 887
2025
Q1 		$18.4K Buy
29
+1
+4% +$688 ﹤0.01% 606
2024
Q4 		$19.9K Hold
28
– – ﹤0.01% 586
2024
Q3 		$29.4K Hold
28
– – ﹤0.01% 493
2024
Q2 		$29.4K Hold
28
– – ﹤0.01% 478
2024
Q1 		$26.9K Hold
28
– – ﹤0.01% 465
2023
Q4 		$24.6K Sell
28
-8
-22% -$6.59K ﹤0.01% 473
2023
Q3 		$29.6K Hold
36
– – ﹤0.01% 419
2023
Q2 		$25.9K Buy
36
+6
+20% +$4.63K ﹤0.01% 422
2023
Q1 		$24.6K Sell
30
-6
-17% -$4.53K ﹤0.01% 424
2022
Q4 		$26K Buy
36
+11
+44% +$8.12K ﹤0.01% 391
2022
Q3 		$17K Hold
25
– – ﹤0.01% 461
2022
Q2 		$15K Hold
25
– – ﹤0.01% 469
2022
Q1 		$17K Hold
25
– – ﹤0.01% 415
2021
Q4 		$16K Hold
25
– – ﹤0.01% 409
2021
Q3 		$15K Hold
25
– – ﹤0.01% 402
2021
Q2 		$14K Hold
25
– – ﹤0.01% 396
2021
Q1 		$12K Buy
+25
New +$12.2K ﹤0.01% 392

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bogart Wealth LLC's REGN Position: Q2 2026 in Review

Bogart Wealth LLC increased its Regeneron Pharmaceuticals (REGN) stake by 10% in Q2 2026, buying an estimated $1.36K and bringing the position to 22 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #916.

Bogart Wealth LLC first reported a position in REGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $29.6K in Q3 2023. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Bogart Wealth LLC held 22 shares of Regeneron Pharmaceuticals worth $13.7K as of Q2 2026.
  • Bogart Wealth LLC bought 2 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.36K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #916 holding.
  • Bogart Wealth LLC first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Bogart Wealth LLC's Regeneron Pharmaceuticals position peaked at $29.6K in Q3 2023.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.